Skip to main content
. Author manuscript; available in PMC: 2022 Apr 7.
Published in final edited form as: Adv Exp Med Biol. 2021;1322:115–138. doi: 10.1007/978-981-16-0267-2_5

Table 5.5.

Small interfering RNA (siRNA) drugs in development

Drug Route Company Clinical trial phase ClinicalTrials.gov identifier
VIR-2218 (ALN-HBV02) Parenteral (SC) Alnylam and Vir Biotech, USA 2 NCT03672188
JNJ-3989 (ARO-HBV) Parenteral (SC) Arrowhead Pharma with Janssen, USA 2a NCT03365947
RG6346 (DCR HBVS) Parenteral (SC) Roche, Switzerland 2/1 NCT03772249
AB-729 [57] Parenteral (SC) Arbutus Biopharma, USA 1 NA

NA not available